vs
Side-by-side financial comparison of BALCHEM CORP (BCPC) and Climb Global Solutions, Inc. (CLMB). Click either name above to swap in a different company.
BALCHEM CORP is the larger business by last-quarter revenue ($270.7M vs $182.4M, roughly 1.5× Climb Global Solutions, Inc.). BALCHEM CORP runs the higher net margin — 14.9% vs 1.8%, a 13.1% gap on every dollar of revenue. On growth, Climb Global Solutions, Inc. posted the faster year-over-year revenue change (32.1% vs 8.1%). Over the past eight quarters, Climb Global Solutions, Inc.'s revenue compounded faster (40.7% CAGR vs 7.5%).
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
Univar Solutions Inc. is a global chemical and ingredients distributor and provider of value-added services.
BCPC vs CLMB — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $270.7M | $182.4M |
| Net Profit | $40.3M | $3.3M |
| Gross Margin | — | 14.5% |
| Operating Margin | 20.5% | 2.1% |
| Net Margin | 14.9% | 1.8% |
| Revenue YoY | 8.1% | 32.1% |
| Net Profit YoY | 8.7% | -9.5% |
| EPS (diluted) | $1.25 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $270.7M | $182.4M | ||
| Q4 25 | $263.6M | $193.8M | ||
| Q3 25 | $267.6M | $161.3M | ||
| Q2 25 | $255.5M | $159.3M | ||
| Q1 25 | $250.5M | $138.0M | ||
| Q4 24 | $240.0M | $161.8M | ||
| Q3 24 | $239.9M | $119.3M | ||
| Q2 24 | $234.1M | $92.1M |
| Q1 26 | $40.3M | $3.3M | ||
| Q4 25 | $39.2M | $7.0M | ||
| Q3 25 | $40.3M | $4.7M | ||
| Q2 25 | $38.3M | $6.0M | ||
| Q1 25 | $37.1M | $3.7M | ||
| Q4 24 | $33.6M | $7.0M | ||
| Q3 24 | $33.8M | $5.5M | ||
| Q2 24 | $32.1M | $3.4M |
| Q1 26 | — | 14.5% | ||
| Q4 25 | 35.6% | 15.4% | ||
| Q3 25 | 35.7% | 15.9% | ||
| Q2 25 | 36.4% | 16.5% | ||
| Q1 25 | 35.2% | 16.9% | ||
| Q4 24 | 36.0% | 19.3% | ||
| Q3 24 | 35.6% | 20.3% | ||
| Q2 24 | 35.5% | 20.2% |
| Q1 26 | 20.5% | 2.1% | ||
| Q4 25 | 19.8% | 4.9% | ||
| Q3 25 | 20.4% | 4.3% | ||
| Q2 25 | 20.1% | 5.0% | ||
| Q1 25 | 20.4% | 3.5% | ||
| Q4 24 | 19.8% | 7.2% | ||
| Q3 24 | 20.0% | 7.1% | ||
| Q2 24 | 19.6% | 4.6% |
| Q1 26 | 14.9% | 1.8% | ||
| Q4 25 | 14.9% | 3.6% | ||
| Q3 25 | 15.1% | 2.9% | ||
| Q2 25 | 15.0% | 3.7% | ||
| Q1 25 | 14.8% | 2.7% | ||
| Q4 24 | 14.0% | 4.3% | ||
| Q3 24 | 14.1% | 4.6% | ||
| Q2 24 | 13.7% | 3.7% |
| Q1 26 | $1.25 | $0.18 | ||
| Q4 25 | $1.21 | $1.51 | ||
| Q3 25 | $1.24 | $1.02 | ||
| Q2 25 | $1.17 | $1.30 | ||
| Q1 25 | $1.13 | $0.81 | ||
| Q4 24 | $1.03 | $1.52 | ||
| Q3 24 | $1.03 | $1.19 | ||
| Q2 24 | $0.98 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $72.9M | $41.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.3B | $118.4M |
| Total Assets | $1.7B | $458.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $72.9M | $41.8M | ||
| Q4 25 | $74.6M | $36.6M | ||
| Q3 25 | $65.1M | $49.8M | ||
| Q2 25 | $65.4M | $28.6M | ||
| Q1 25 | $49.9M | $32.5M | ||
| Q4 24 | $49.5M | $29.8M | ||
| Q3 24 | $73.7M | $22.1M | ||
| Q2 24 | $63.7M | $48.4M |
| Q1 26 | $1.3B | $118.4M | ||
| Q4 25 | $1.3B | $116.6M | ||
| Q3 25 | $1.3B | $109.3M | ||
| Q2 25 | $1.3B | $105.2M | ||
| Q1 25 | $1.2B | $95.6M | ||
| Q4 24 | $1.1B | $90.6M | ||
| Q3 24 | $1.2B | $87.7M | ||
| Q2 24 | $1.1B | $79.8M |
| Q1 26 | $1.7B | $458.8M | ||
| Q4 25 | $1.7B | $460.2M | ||
| Q3 25 | $1.7B | $376.1M | ||
| Q2 25 | $1.7B | $420.7M | ||
| Q1 25 | $1.6B | $370.1M | ||
| Q4 24 | $1.6B | $469.2M | ||
| Q3 24 | $1.6B | $371.9M | ||
| Q2 24 | $1.6B | $302.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $40.1M | — |
| Free Cash FlowOCF − Capex | $33.8M | — |
| FCF MarginFCF / Revenue | 12.5% | — |
| Capex IntensityCapex / Revenue | 2.3% | — |
| Cash ConversionOCF / Net Profit | 0.99× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $40.1M | — | ||
| Q4 25 | $67.3M | $-11.9M | ||
| Q3 25 | $65.6M | $22.2M | ||
| Q2 25 | $47.3M | $-2.2M | ||
| Q1 25 | $36.5M | $8.5M | ||
| Q4 24 | $52.3M | $16.0M | ||
| Q3 24 | $51.3M | $-3.6M | ||
| Q2 24 | $45.0M | $7.3M |
| Q1 26 | $33.8M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | 12.5% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | 2.3% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | 0.99× | — | ||
| Q4 25 | 1.72× | -1.70× | ||
| Q3 25 | 1.63× | 4.73× | ||
| Q2 25 | 1.23× | -0.37× | ||
| Q1 25 | 0.98× | 2.30× | ||
| Q4 24 | 1.56× | 2.29× | ||
| Q3 24 | 1.52× | -0.66× | ||
| Q2 24 | 1.40× | 2.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
